{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017286","form_type":"8-K","ticker":"PRPH","cik":"0000868278","company_name":"ProPhase Labs, Inc.","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.525537+00:00","generated_at":"2026-05-18T11:32:07.029611+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ProPhase Labs regains Nasdaq compliance after appointing new independent director","bullets":["Appointed Carolina Abenante as independent director on June 20, 2025.","Abenante will join the Audit Committee effective July 19, 2025, the day after the annual meeting.","Nasdaq confirmed compliance with Listing Rule 5605(c)(2) on June 25, 2025, closing the matter.","Non-compliance stemmed from Eleanor McBrier's resignation in September 2024, causing an audit committee vacancy."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017286","json":"https://secwatch.observer/filing/0001641172-25-017286.json","markdown":"https://secwatch.observer/filing/0001641172-25-017286.md","text":"https://secwatch.observer/filing/0001641172-25-017286.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/868278/000164117225017286/0001641172-25-017286-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/868278/000164117225017286/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T11:32:07.029611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d638031d9a5b07947243e23be31d7b7a4167de5b","claim":"ProPhase Labs, Inc. received a nasdaq deficiency notice notice regarding other (rules 5605(c)(2)(A), 5605(c)(4), 5605(c)(2), 5605).","evidence_excerpt":"mittee effective July 19, 2025, the day following the Company’s 2025 Annual Meeting. In response to the Company’s notification of Ms. Abenante’s appointment to the Board, on June 25, 2025, the Company received a letter from Nasdaq informing the Company that it was now in compliance with Nasdaq Rule 5605(c)(2) and that the matter is now closed. Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/868278/000164117225017286/0001641172-25-017286-index.htm","confidence":0.82,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Rules","value":"5605(c)(2)(A), 5605(c)(4), 5605(c)(2), 5605"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}